Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1

Yan Li1, Dongmei Zhou1, Yinghui Ren2

  • 1a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.

Autophagy
|September 14, 2018
PubMed

Insights

MicroRNA-223 (Mir223) deficiency ameliorates neuroinflammation in experimental autoimmune encephalomyelitis (EAE) by enhancing autophagy. Autophagy regulation via Mir223 and its target ATG16L1 offers potential therapeutic strategies for EAE.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Microglia are central nervous system immune cells crucial for neuronal health.
  • Autophagy, a cellular degradation process, is vital for maintaining cellular homeostasis and implicated in various diseases.
  • MicroRNAs (miRNAs) are emerging regulators of autophagy, making their role in neuroinflammation a key research area.

Purpose of the Study:

  • To investigate the role of microRNA-223 (Mir223) in regulating autophagy in microglia.
  • To elucidate the impact of Mir223 on experimental autoimmune encephalomyelitis (EAE), a model of neuroinflammation.
  • To identify downstream targets of Mir223 involved in autophagy modulation.

Main Methods:

  • Utilized a mouse model of EAE with and without Mir223.
  • Administered autophagy inhibitor 3-methyladenine (3-MA) to assess its effects on EAE severity.
  • Analyzed protein expression of autophagy-related genes (ATG16L1, LC3-II) in microglia and bone marrow-derived macrophages.
  • Performed luciferase reporter assays to confirm direct targeting of ATG16L1 by Mir223.

Main Results:

  • Mir223 deficiency significantly reduced CNS inflammation, demyelination, and clinical symptoms in EAE.
  • Mir223 deficiency led to increased autophagy and resting microglia in the brain.
  • Inhibition of autophagy aggravated EAE symptoms, irrespective of Mir223 status.
  • Mir223 directly targets ATG16L1, a key autophagy-related gene, and its modulation impacts autophagic activity.

Conclusions:

  • Mir223 acts as a negative regulator of autophagy in microglia.
  • Mir223 deficiency ameliorates EAE by enhancing autophagy, with ATG16L1 identified as a direct target.
  • Targeting the Mir223-ATG16L1 axis represents a potential therapeutic strategy for neuroinflammatory diseases like EAE.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
62.2K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

4.0K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.3K
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.4K